Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Asset Writedowns and Impairment (2019 - 2021)

Outset Medical (OM) has disclosed Asset Writedowns and Impairment for 3 consecutive years, with $5000.0 as the latest value for Q1 2021.

  • On a quarterly basis, Asset Writedowns and Impairment fell 54.55% to $5000.0 in Q1 2021 year-over-year; TTM through Dec 2021 was $5000.0, a 58.33% decrease, with the full-year FY2021 number at $5000.0, down 58.33% from a year prior.
  • Asset Writedowns and Impairment was $5000.0 for Q1 2021 at Outset Medical, up from -$17000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $87000.0 in Q2 2020 to a low of -$208000.0 in Q4 2019.
  • A 3-year average of -$31833.3 and a median of -$6000.0 in 2020 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: surged 91.83% in 2020, then plummeted 54.55% in 2021.
  • Outset Medical's Asset Writedowns and Impairment stood at -$208000.0 in 2019, then soared by 91.83% to -$17000.0 in 2020, then skyrocketed by 129.41% to $5000.0 in 2021.
  • Per Business Quant, the three most recent readings for OM's Asset Writedowns and Impairment are $5000.0 (Q1 2021), -$17000.0 (Q4 2020), and -$69000.0 (Q3 2020).